Skip to content

Apotheek Bulskamp: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Bulskamp

BE 0670.452.122
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€144,462
2024 · €99,270+€45,192
Equity
€310,435
2024 · €610,435-€300,000
Cash
€135,105
2024 · €139,593-€4,489
Balance sheet total
€968,752
2024 · €938,664+€30,088

Largest movements

2024 to 2025
Assets
  • Current investments +€48,624

    up €48,624 (+10.2%), from €474,696 to €523,319

  • Intangible fixed assets -€36,500

    down €36,500 (-48.0%), from €76,042 to €39,542

  • Receivables within one year +€27,181

    up €27,181 (+33.8%), from €80,313 to €107,495

    of which Trade receivables: +€25,063

Equity and liabilities
  • Other debts +€326,120

    up €326,120 (+130%), from €250,823 to €576,942

  • Reserves -€300,000

    down €300,000 (-83.2%), from €360,435 to €60,435

    of which Distributable reserves: -€300,000

Income statement
  • Financial income +€30,711

    up €30,711 (+678%), from €4,527 to €35,238

  • Gross operating margin +€13,775

    up €13,775 (+7.3%), from €189,418 to €203,193

  • Taxes +€5,209

    up €5,209 (+19.1%), from €27,265 to €32,474

  • Financial charges -€3,412

    down €3,412 (-17.4%), from €19,634 to €16,222

  • Depreciation -€2,409

    down €2,409 (-5.3%), from €45,626 to €43,216

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €99,270
Gross operating margin +€13,775
Depreciation +€2,409
Write-downs +€166
Other operating charges -€72
Financial income +€30,711
Financial charges +€3,412
Taxes -€5,209
Result 2025 €144,462
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€488,597
Investment -€48,624
Financing -€444,462
Cash 2024 €139,593
Net result for the year +€144,462
Depreciation +€43,216
Stocks and contracts -€2,257
Receivables within one year -€27,181
Deferred charges and accrued income +€269
Trade debts +€6,201
Tax, wage and social debts +€1,735
Other debts +€326,120
Accrued charges and deferred income -€3,968
Current investments -€48,624
Contributions, distributions and other -€444,462
Cash 2025 €135,105
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €938,664 €968,752 +€30,088 +3.2%
Fixed assets 21/28 €92,826 €49,610 -€43,216 -46.6%
Intangible fixed assets 21 €76,042 €39,542 -€36,500 -48.0%
Tangible fixed assets 22/27 €16,784 €10,068 -€6,716 -40.0%
Plant, machinery and equipment 23 €11,184 €5,868 -€5,316 -47.5%
Furniture and vehicles 24 €5,600 €4,200 -€1,400 -25.0%
Current assets 29/58 €845,838 €919,143 +€73,305 +8.7%
Stocks and contracts in progress 3 €140,687 €142,944 +€2,257 +1.6%
Stocks 30/36 €140,687 €142,944 +€2,257 +1.6%
Amounts receivable within one year 40/41 €80,313 €107,495 +€27,181 +33.8%
Trade receivables 40 €72,403 €97,466 +€25,063 +34.6%
Other amounts receivable 41 €7,911 €10,029 +€2,118 +26.8%
Current investments 50/53 €474,696 €523,319 +€48,624 +10.2%
Cash at bank and in hand 54/58 €139,593 €135,105 -€4,489 -3.2%
Deferred charges and accrued income 490/1 €10,549 €10,280 -€269 -2.6%
Total equity and liabilities 10/49 €938,664 €968,752 +€30,088 +3.2%
Equity 10/15 €610,435 €310,435 -€300,000 -49.1%
Contributions 10/11 €250,000 €250,000 = 0.0%
Reserves 13 €360,435 €60,435 -€300,000 -83.2%
Tax-exempt reserves 132 €12,000 €12,000 = 0.0%
Distributable reserves 133 €348,435 €48,435 -€300,000 -86.1%
Amounts payable 17/49 €328,229 €658,317 +€330,088 +101%
Amounts payable within one year 42/48 €310,126 €644,182 +€334,057 +108%
Trade debts 44 €52,188 €58,389 +€6,201 +11.9%
Suppliers 440/4 €52,188 €58,389 +€6,201 +11.9%
Taxes, remuneration and social security 45 €7,115 €8,850 +€1,735 +24.4%
Taxes 450/3 €1,284 €2,999 +€1,715 +134%
Remuneration and social security 454/9 €5,831 €5,851 +€20 +0.4%
Other amounts payable 47/48 €250,823 €576,942 +€326,120 +130%
Accrued charges and deferred income 492/3 €18,103 €14,135 -€3,968 -21.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €45,626 €43,216 -€2,409 -5.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €166 - -€166
Other operating charges 640/8 €1,984 €2,056 +€72 +3.6%
Gross operating margin 9900 €189,418 €203,193 +€13,775 +7.3%
Operating profit (loss) 9901 €141,643 €157,920 +€16,278 +11.5%
Financial income 75/76B €4,527 €35,238 +€30,711 +678%
Recurring financial income 75 €4,527 €35,238 +€30,711 +678%
Financial charges 65/66B €19,634 €16,222 -€3,412 -17.4%
Recurring financial charges 65 €19,634 €16,222 -€3,412 -17.4%
Profit (loss) for the period before taxes 9903 €126,535 €176,936 +€50,401 +39.8%
Income taxes 67/77 €27,265 €32,474 +€5,209 +19.1%
Profit (loss) for the period 9904 €99,270 €144,462 +€45,192 +45.5%
Profit (loss) for the period to be appropriated 9905 €99,270 €144,462 +€45,192 +45.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.